A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

NCT06268873 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

2554

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease and Hypertension

Interventions

DRUG: Baxdrostat/dapagliflozin
DRUG: Dapagliflozin in combination with placebo

Sponsor

AstraZeneca